SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001493152-22-028081
Filing Date
2022-10-11
Accepted
2022-10-11 12:46:00
Documents
8
Period of Report
2022-10-11

Document Format Files

Seq Description Document Type Size
1 form6-k.htm 6-K 21540
2 ex10-13.htm EX-10.13 11157
3 ex10-14.htm EX-10.14 13296
4 ex10-26.htm EX-10.26 23390
5 ex10-13_001.jpg GRAPHIC 5974
6 ex10-14_001.jpg GRAPHIC 6296
7 ex10-26_001.jpg GRAPHIC 3322
8 ex10-26_002.jpg GRAPHIC 3321
  Complete submission text file 0001493152-22-028081.txt   97245
Mailing Address 789 WEST PENDER STREET SUITE 810 VANCOUVER A1 V6C 1H2
Business Address 789 WEST PENDER STREET SUITE 810 VANCOUVER A1 V6C 1H2 604-687-2038
Avricore Health Inc. (Filer) CIK: 0001355736 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 000-51848 | Film No.: 221303358
SIC: 2834 Pharmaceutical Preparations